These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10448301)

  • 61. Low frequency of p53 mutations in human thyroid tumours; p53 and Ras mutation in two out of fifty-six thyroid tumours.
    Salvatore D; Celetti A; Fabien N; Paulin C; Martelli ML; Battaglia C; Califano D; Monaco C; Viglietto G; Santoro M; Fusco A
    Eur J Endocrinol; 1996 Feb; 134(2):177-83. PubMed ID: 8630516
    [TBL] [Abstract][Full Text] [Related]  

  • 62. FHIT gene alterations in head and neck squamous cell carcinomas.
    Virgilio L; Shuster M; Gollin SM; Veronese ML; Ohta M; Huebner K; Croce CM
    Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9770-5. PubMed ID: 8790406
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors.
    Kholodnyuk ID; Szeles A; Yang Y; Klein G; Imreh S
    Cancer Res; 2000 Dec; 60(24):7119-25. PubMed ID: 11156420
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Alterations of the FHIT gene in human hepatocellular carcinoma.
    Yuan BZ; Keck-Waggoner C; Zimonjic DB; Thorgeirsson SS; Popescu NC
    Cancer Res; 2000 Feb; 60(4):1049-53. PubMed ID: 10706123
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Analysis of FHIT transcripts in cervical and endometrial cancers.
    Su TH; Wang JC; Tseng HH; Chang CP; Chang TA; Wei HJ; Chang JG
    Int J Cancer; 1998 Apr; 76(2):216-22. PubMed ID: 9537583
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Variable FHIT transcripts in non-neoplastic tissues.
    Panagopoulos I; Thelin S; Mertens F; Mitelman F; Aman P
    Genes Chromosomes Cancer; 1997 Aug; 19(4):215-9. PubMed ID: 9258655
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [FHIT gene is abnormal in laryngeal carcinoma].
    Fu W; Wu D; Zhang X
    Zhonghua Zhong Liu Za Zhi; 1999 Nov; 21(6):436-8. PubMed ID: 11776620
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
    Garinis GA; Gorgoulis VG; Mariatos G; Zacharatos P; Kotsinas A; Liloglou T; Foukas P; Kanavaros P; Kastrinakis NG; Vassilakopoulos T; Vogiatzi T; Field JK; Kittas C
    J Pathol; 2001 Jan; 193(1):55-65. PubMed ID: 11169516
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
    J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Allelic loss and down-regulation of FHIT gene expression in esophageal squamous cell carcinoma].
    Liu FX; Huang XP; Zhao CX; Xu X; Han YL; Cai Y; Wu RL; Wu M; Zhan QM; Wang MR
    Ai Zheng; 2004 Sep; 23(9):992-8. PubMed ID: 15363189
    [TBL] [Abstract][Full Text] [Related]  

  • 71. FHIT (fragile histidine triad) gene analysis in cervical intraepithelial neoplasia.
    Liu FS; Hsieh YT; Chen JT; Ho ES; Hung MJ; Lin AJ
    Gynecol Oncol; 2001 Aug; 82(2):283-90. PubMed ID: 11531281
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Loss of heterozygosity at the FHIT gene in different solid human tumours and its association with survival in colorectal cancer patients.
    Petursdottir TE; Hafsteinsdottir SH; Jonasson JG; Moller PH; Thorsteinsdottir U; Huiping C; Egilsson V; Ingvarsson S
    Anticancer Res; 2002; 22(6A):3205-12. PubMed ID: 12530066
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The FHIT gene in oral squamous cell carcinoma: allelic imbalance is frequent but cDNA aberrations are uncommon.
    Pateromichelakis S; Lee G; Langdon JD; Partridge M
    Oral Oncol; 2000 Mar; 36(2):180-8. PubMed ID: 10745170
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B.
    Boldog F; Gemmill RM; West J; Robinson M; Robinson L; Li E; Roche J; Todd S; Waggoner B; Lundstrom R; Jacobson J; Mullokandov MR; Klinger H; Drabkin HA
    Hum Mol Genet; 1997 Feb; 6(2):193-203. PubMed ID: 9063739
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Aberrant splicing of FHIT transcripts in human gastric cancer cell lines.
    Lee SH; Kim HY; Kim TJ; Park HK; Kim WH; Woo KM; Cho MH
    Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):39-49. PubMed ID: 15080495
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Aberrant expression and deletion of FHIT gene in leukemias.
    Wang L; Dong LJ; Tian F; Liu GX; Li CH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Apr; 11(2):153-60. PubMed ID: 12744737
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.
    Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT
    Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
    Burke L; Khan MA; Freedman AN; Gemma A; Rusin M; Guinee DG; Bennett WP; Caporaso NE; Fleming MV; Travis WD; Colby TV; Trastek V; Pairolero PC; Tazelaar HD; Midthun DE; Liotta LA; Harris CC
    Cancer Res; 1998 Jun; 58(12):2533-6. PubMed ID: 9635574
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Normal FHIT transcripts in renal cell cancer- and lung cancer-derived cell lines, including a cell line with a homozygous deletion in the FRA3B region.
    van den Berg A; Draaijers TG; Kok K; Timmer T; Van der Veen AY; Veldhuis PM; de Leij L; Gerhartz CD; Naylor SL; Smith DI; Buys CH
    Genes Chromosomes Cancer; 1997 Aug; 19(4):220-7. PubMed ID: 9258656
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas.
    Foja S; Goldberg M; Schagdarsurengin U; Dammann R; Tannapfel A; Ballhausen WG
    Liver Int; 2005 Dec; 25(6):1202-8. PubMed ID: 16343073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.